Sentonix, Inc. — Form D
Sentonix, Inc. of ARLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-03. The offering totals $5.5M, of which $5.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-10-03
- Form: D
- Accession: 0001973076-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.2M
- Remaining: $294K
- Minimum investment: $10K
- Investors: 10
- Date of first sale: 2024-09-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-525715
Issuer
- Name: Sentonix, Inc.
- CIK: 0002039609
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1167 MASSACHUSETTS AVE, ARLINGTON, MA, 02476
- Phone: 617-388-6440
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jack Hoppin | Director | Natick, MA |
| Karl Schmidt | Executive Officer | Arlington, MA |
| John Beaver | Director | Redwood City, CA |
| John Beaver | Executive Officer | Redwood City, CA |
| Kenan Turnacioglu | Director | Arlington, MA |
| Kenan Turnacioglu | Executive Officer | Arlington, MA |
Other filings by this issuer (1)
More